Background
Transmyocardial delivery of stem cells in the setting of acute myocardial ischemia has shown promise to prevent adverse ventricular remodeling 1 . However, the efficacy is limited by poor cell retention and low survival rates, even for autologous cells. Intrapericardial delivery of microencapsulated stem cells may offer a local and minimally invasive route to enhance cell survival and retention. In this study, we assess the delivery of human mesenchymal stem cells (hMSCs) in a radiopaque microcapsule to the pericardium using x-ray fused with magnetic resonance imaging (XFM) in a porcine model.
Methods
Stem cell microencapsulation was performed using a modification of the alginate microencapsulation method by the addition of 10% (w/v) BaSO4 (BaCaps, Fig.1A ) 2 . Female Yorkshire pigs (~25 kg, n=7) were randomized to receive either empty BaCaps (~10 ml), naked hMSCs (1x10 8 ), saline, or BaCaps with hMSCs (8x10 7 ) using a percutaneous approach. Prior to delivery, cine breathheld short-axis images were acquired to determine ventricular function (Argus, Siemens). A navigator-gated 3D whole heart MRI (1.5T Espree, Siemens SSFP, TR/ TE=290/1.67 ms, FOV=320x240 mm, image matrix=256x173, iPAT=2, slice=64, slice thickness=2 mm) was also obtained to define ventricular borders for intrapericardial injection. A cardiac-gated c-arm CT (dynaCT, Axiom Artis dFA, Siemens, 190°rotation; 0.5°a ngle; 20s acquisition; 48 cm FOV) was then obtained and fused with the whole heart MRI and overlaid on live fluoroscopy to guide percutaneous access to the pericardial space. For chronic studies, MRI and c-arm CT imaging were repeated one week after injection. Animals were sacrificed immediately or one week postdelivery for histological analysis.
Results
The viability of Ba-encapsulated hMSCs was 94.8±6% two days after encapsulation (Fig.1B) . Using XFM (Fig.1C) , successful puncture and delivery of BaCaps or Ba-encapsulated hMSCs was achieved in all animals. BaCaps were detected on fluoroscopic and c-arm CT images immediately and one week after delivery (Fig.1D ). Whereas BaCaps were free floating immediately after delivery, at one week the BaCaps had consolidated as a pseudo epicardial tissue patch. Cardiac function was maintained 1 week post-delivery (LVEF: 36.8±4% at baseline vs. 41.5±5% at 1 week, n=5). Pericardial adhesions and effusion were absent at one week.
Conclusions
XFM-guided intrapericardial injection of Ba-encapsulated hMSCs was safe and reliable. This approach holds promise for safe delivery of allogeneic cellular therapeutics to the heart in patients without pericardial effusion.
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